Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples